Press Releases & News


01.07.2008mtm laboratories appoints Bob Silverman as CEO
17.04.2008mtm laboratories today announced the signing for a third tranche of Euro 9.6 million to its Series C funding. This addition increases the total for the round to Euro 31.6 million (USD 50 million) in equity
15.05.2007Studies present compelling data on the p16INK4a biomarker at the 16th International Congress of Cytology
04.01.2007mtm laboratories opens subsidiaries in Italy, France and Spain to support the commercialization of its diagnostic products.
03.01.2007mtm laboratories launches proprietary CINtec® Histology and CINtec® Cytology kits.
09.10.2006mtm laboratories raises €22 million in Series C financing.
11.07.2006mtm laboratories makes two senior clinical research appointments.
04.05.2006Studies presented at EUROGIN highlight potential of p16INK4a as biomarker for early detection and diagnosis of cervical cancer.
02.05.2006mtm laboratories and Dako restructure license agreement regarding p16INK4a CINtec®.
02.08.2005mtm laboratories AG establishes US subsidiary, naming Robert Silverman President.
13.10.2004mtm laboratories achieves ISO 9001 and ISO 13485 certification for design, manufacturing and distribution of In Vitro Diagnostics.
03.05.2004mtm laboratories announces granting of US patent covering its CINtec™ technology.
22.03.2004mtm laboratories extends its supervisory board.
16.12.2003Contribution to assessment of cervical cancer.


Print Sitemap Contact Imprint General Terms and Conditions of Use

footer logo ® mtm laboratories AG, all rights reserved
Products


News